Conference Proceedings

The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy

Mel Michel Villaluz, Lysa Boisse Lomax, Trupti Jadhav, J Helen Cross, Ingrid E Scheffer

Developmental Medicine & Child Neurology | WILEY | Published : 2018

University of Melbourne Researchers


Funding Acknowledgements

Dr Villaluz received Fellowship support from the Epilepsy Society of Australia. Dr Boisse Lomax received Fellowship support from the Detweiler Travelling Fellowship (Royal Canadian College of Physicians and Surgeons) and the Cecil Patience Reid Fellowship (Queen's University Faculty of Health Sciences). Funding was also provided by the National Health and Medical Research Council of Australia, and by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. Dr Scheffer has served on scientific advisory boards for UCB and Janssen-Cilag Europe, Middle-East and Africa (EMEA); may accrue future revenue on pending patent WO61/010176 (filed: 2008): Therapeutic Compound; has received speaker honoraria from Athena Diagnostics, UCB, GlaxoSmithKline, Biocodex, and Janssen-Cilag EMEA; and has received funding for travel from Athena Diagnostics, UCB, Biocodex, GlaxoSmithKline, and Janssen-Cilag EMEA. Dr Cross has received speaker's or consultancy fees or research grants, or both, paid to her department from Esai, GlaxoSmithKline, Sanofi, UCB, Shire, Vitaflo, Nutricia, and has participated as an investigator in clinical trials for GW Pharma and Zogenix. The remaining authors have stated that they had no interests which might be perceived as posing a conflict or bias.